Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148341 · ClinicalTrials.gov registry record · NA
Implementation of the Hospital to Home (H2H) Heart Failure Initiative
A NA study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT02148341: Completed NA study, sponsored by VA Palo Alto Health Care System.
NCT02148341 is a NA study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02148341, a NA study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This study determines if a community of practice of clinicians and quality improvement specialists can be used to implement a national quality initiative known as Hospital to Home (H2H). This quality initative is designed to reduced readmission rates for patients with heart failure or heart attack by improving the transition of care upon discharge.
Primary Outcome
H2H enrollment by the facility as determined by the H2H program of the American College of Cardiology and Institute for Healthcare Improvement
Interventions
- OTHER Usual Care
- OTHER Community of Practice Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT02148341 record still lists
NCT02148341 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02148341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02148341 about?
NCT02148341 is a clinical study titled "Implementation of the Hospital to Home (H2H) Heart Failure Initiative". This study determines if a community of practice of clinicians and quality improvement specialists can be used to implement a national quality initiative known as Hospital to Home (H2H). This quality initative is designed to reduced readmission rates for patients with heart failure or heart attack b...
What is the current status of trial NCT02148341?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2010-01. Estimated completion is 2013-07.
What interventions are being tested in trial NCT02148341?
The interventions under investigation include: Usual Care (OTHER), Community of Practice Facilitation (OTHER).
Who is sponsoring clinical trial NCT02148341?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02148341's enrollment target sits among peer trials
122 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia